Last reviewed · How we verify
Placebo Comparator: Arm B - Control — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Comparator: Arm B - Control (Placebo Comparator: Arm B - Control) — Syntara. A placebo comparator arm provides no active therapeutic intervention and serves as a control baseline in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Comparator: Arm B - Control TARGET | Placebo Comparator: Arm B - Control | Syntara | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Comparator: Arm B - Control CI watch — RSS
- Placebo Comparator: Arm B - Control CI watch — Atom
- Placebo Comparator: Arm B - Control CI watch — JSON
- Placebo Comparator: Arm B - Control alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Comparator: Arm B - Control — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-comparator-arm-b-control. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing